Objective We sought to identify fetal heart rate (FHR) characteristics that are associated with neonatal encephalopathy (NE).
Introduction
Neonatal encephalopathy (NE) is a clinical condition identified shortly after birth in term or near term infants that is characterised by abnormal neurological function. Affected infants often present with a decreased level of consciousness or seizures, as well as difficulty initiating and maintaining respirations and abnormal reflexes or tone. 1 The reported incidence of this condition ranges from 2 to 6/1000 live births. 2 Although a relatively uncommon clinical outcome, infants with NE have higher rates of mortality and are at risk for long-term neurodevelopmental disability. 3, 4 Unfortunately, there are no evidence-based interventions to prevent the occurrence of NE, due in part to a lack of understanding of the aetiology of this complex condition as well as multiple diverse causal pathways being implicated. Placental, inflammatory and genetic factors have all been suggested to have a role in the pathogenesis . [5] [6] [7] [8] Because of this, the most recent American College of Obstetricians and Gynecologists (ACOG) and American Academy of Pediatrics (AAP) Task Force on Neonatal Encephalopathy promoted the use of the term neonatal encephalopathy to describe the condition, rather than more specific terminology such as perinatal asphyxia or hypoxic-ischaemic encephalopathy. Although peripartum hypoxia and cerebral ischaemia are possible aetiologies of NE, in practice it can be difficult to establish a definitive cause. The Task Force recommended the performance of a multidimensional review to evaluate all possible contributing factors in each case of NE. 1 Electronic fetal monitoring (EFM) prior to delivery is one of the key components of this assessment.
EFM was originally developed as a tool to improve infant morbidity in the peripartum period and reduce rates of cerebral palsy. 9 Although there is some evidence that EFM reduces the risk of neonatal seizures, an improvement in long-term neurological morbidity or neonatal mortality with use of this technology has not been demonstrated. 10 A number of studies have shown an association between specific EFM patterns and fetal acidaemia. [11] [12] [13] [14] Low umbilical cord pH is associated with neonatal mortality and neurological morbidity and, as such, it is commonly used as a proxy for NE. 15 However, there is a general paucity of data relating specific EFM features to the clinical diagnosis of NE. [16] [17] [18] Establishing the relation between intrapartum events and the occurrence NE is of particular interest because there may be a potential to mitigate the risk of this adverse outcome. Therefore, the objective of this study was to identify fetal heart rate (FHR) characteristics prior to delivery that are associated with NE. We hypothesised that category III FHR tracings, as described by the Eunice Kennedy Shriver National Institutes of Child Health and Human Development (NICHD) and ACOG endorsed system of EFM interpretation, 19 would be associated with NE.
Methods
We performed a retrospective case-control study comparing EFM patterns among women whose infants were diagnosed with NE with a group of women whose infants were unaffected. This research involved collaboration between investigators at the International Peace Health Hospital of Shanghai Jiao Tong University in Shanghai, China, and The Ohio State University College of Medicine in Columbus, OH, USA. All women included in the study delivered at the International Peace Health Hospital from 2006 to 2015. Approval was granted by the research ethics committee at that institution prior to commencement of the study. All data shared between the institutions were deidentified.
Cases of NE were identified using ICD-10 codes within the infant medical record. A review of the maternal and neonatal medical records was conducted to confirm the diagnosis. NE was defined as a clinical syndrome present from birth and characterised by difficulty initiating and/or maintaining respiration, altered consciousness and abnormal tone and reflexes with or without seizures. The control group was composed of a sample of women whose infants were not diagnosed with NE, and were frequency-matched by year to the cases. For every case, there were three women included in the control group. We used a 1:3 match to dilute the sample of FHR tracings to be reviewed out of concern that physicians might over-interpret tracing characteristics if they knew there was a high percentage of NE in the sample. Additional inclusion criteria were singleton gestation and gestational age ≥36 weeks at the time of delivery. Women carrying fetuses with prenatally diagnosed major congenital malformations or known genetic abnormalities were also excluded from the analysis. Finally, we excluded women who had an elective caesarean delivery or were missing FHR data within 60 minutes of delivery.
Trained research staff abstracted data from maternal and infant medical records. Maternal demographics, past medical and surgical history, and prenatal obstetric care information were collected. Gestational age was calculated based on the best obstetric estimate, which incorporates last menstrual period as well as the first ultrasound in the pregnancy. Maternal body mass index was calculated using prepregnancy weight and height (kg/m 2 ). Women were classified as having a hypertensive disorder if they had a diagnosis of chronic hypertension, pre-eclampsia or gestational hypertension. Data regarding obstetric care during labour were also collected including the presence of maternal fever prior to delivery, use of oxytocin for either augmentation or induction, mode of delivery and the occurrence of clinically diagnosed sentinel events such as placental abruption, cord prolapse or uterine rupture. Arterial cord gas results were recorded if they were available. Neonatal outcome data included birthweight, Apgar score at 5 minutes, neonatal intensive care unit (NICU) admission, intubation, seizures within 24 hours of delivery, hypoglycaemia and neonatal death, defined as death within the first 28 days of life. The number of infants with birthweight <10 th percentile for gestational age in each group was determined using a published gender-specific, population-based Chinese birthweight reference. 20 Two maternal-fetal medicine physicians blinded to clinical outcome independently reviewed each study participant's FHR tracing. The physicians who participated had previously completed a national EFM certification examination (National Certification Corporation, Chicago, IL, USA). For each woman, tracings from two different time periods were reviewed: (1) an admission tracing that was on average 60 minutes in duration and (2) the last 30 minutes of available tracing prior to delivery. The FHR tracings were assessed for: (1) tachycardia or bradycardia, (2) baseline variability, (3) accelerations, (4) early, variable, late or prolonged decelerations and (5) fetal heart rate category. Variable and late decelerations were further characterised as recurrent if they occurred with at least half of the contractions. FHR characteristics were defined using guidelines supported by the NICHD and ACOG. 19 Under this classification system, category I tracings are defined as including all of the following characteristics: baseline rate between 110 and 160 beats per minute (bpm), moderate variability, and absence of late or variable decelerations. Category III tracings are defined as (1) absent variability with recurrent late decelerations, recurrent variable decelerations or bradycardia or (2) sinusoidal pattern. Category II tracings include those patterns that do not meet the more stringent criteria of categories I or III. The severity of variable decelerations was also assessed based on the definition used in the five-tiered system proposed by Parer and Ikeda. 21 Severe variable decelerations were defined as meeting one of two criteria: (1) lasting ≥60 seconds with a nadir rate <70 bpm or (2) lasting ≥2 minutes with a nadir rate <80 beats bpm. Overall discrepancies in FHR variability or category status of either the admission or delivery tracing were adjudicated by an additional pair of reviewers. These reviewers (H.A.F. and M.B.L.) were blinded to the assessments of the initial reviewers and together reached a consensus regarding evaluation of the tracing.
Statistical analyses
Baseline demographic characteristics, antenatal exposures and intrapartum factors present among women with an infant diagnosed with NE were compared with those in women whose infants were unaffected. Categorical variables were compared using the Chi-square test and continuous variables were compared using a Wilcoxon rank-sum test. With the intent to further characterise the infants who were diagnosed with NE, we described the prevalence of neonatal outcomes that have previously been reported to be associated with NE, including Apgar score <7 at 5 minutes, intubation, neonatal seizures, hypoglycaemia, NICU admission and death.
FHR tracing category on admission was compared in the NE and control groups. A more detailed analysis of the last 30 minutes of EFM prior to delivery was conducted in which not only FHR category, but also specific characteristics of the FHR tracings were compared. In the assessment of individual characteristics of EFM patterns, minimal and absent variability were grouped together because prior research has shown that the differentiation between absent and minimal variability is often difficult, 22 and both findings are associated with an increased risk of fetal acidosis. 11, 12 Multivariable logistic regression was used to estimate the adjusted odds of NE while adjusting for confounding variables.
We performed a sensitivity analysis in which we compared FHR tracings prior to delivery in women with infants with a clinical diagnosis of NE and arterial cord pH <7.1 with women in the control group. In an additional analysis, we sought to identify whether there were individual FHR characteristics associated with NE in the subgroup of women with category II tracings prior to delivery. Lastly, we excluded women who had an emergency caesarean delivery without labour from the analysis, as this group may differ from women who laboured in terms of specific risk factors for NE and opportunities for intervention. Interobserver agreement of each tracing characteristic based on the initial reviews was assessed using a kappa statistic. All statistical analyses were performed using STATA software version 14.0 (STATACorp, College Station, TX, USA).
Results
Initially, 120 women were identified whose infants had been diagnosed with NE based on review of the medical record, and 380 women in the control group. However, upon reviewing the FHR tracings, it was found that 139 women had no FHR tracing data within 60 minutes of delivery. This likely reflects the high rate of elective caesarean delivery in China 23 and the fact that at the International Peace Health Hospital, women undergoing elective caesarean often have an admission FHR tracing but no monitoring just prior to caesarean delivery. An additional 19 women in the control group were also found to have had an elective caesarean delivery and were excluded. Our final sample for analysis included 342 women, 109 women in the NE group and 233 women in the control group.
The two groups were similar in terms of parity, rates of prior caesarean delivery, exposure to oxytocin and presence of maternal co-morbidities, including hypertension and gestational diabetes (Table 1) . However, women in the NE group were older and delivered at a slightly lower gestational age. They were also more likely to be uninsured, overweight or obese, and to have conceived with assisted reproductive technology. Approximately a quarter of women whose infants had NE had a documented maternal fever prior to delivery (24.8 vs. 6.0%). A sentinel event preceded delivery in 13.8% of women in the NE group (placental abruption, n = 9; cord prolapse, n = 2; uterine rupture, n = 4), whereas only two (0.9%) instances of placental abruption occurred in the control group. There was also a longer time period with no fetal monitoring immediately prior to delivery in the NE group, a finding that may be related to the higher rates of operative delivery in this group compared with controls. In the NE group, 13 women (11.9%) had an operative vaginal delivery and 55 women (50.5%) were delivered by caesarean, compared with 17 women (7.3%) and 28 women (12.0%), respectively, in the control group. Of the 55 caesareans performed in women whose infants had NE, 52.7% were performed intrapartum and 47.3% emergently in women who were not labouring. In the control group, 60.7% of caesareans were intrapartum and 39.3% emergent without labour. The average birthweight of infants with NE was lower than that of infants in the control group, with 11.0% weighing <10 th percentile for gestational age vs. 3.9%. As expected, infants who were diagnosed with NE experienced greater morbidity and higher rates of mortality (Supporting Information Table S1 ). Approximately 70% of infants in the NE group had a 5-minute Apgar score <7 vs. none in the control group. There were no cord gases collected in the control group, but among those in the NE group, 31 infants (28.4%) had an arterial cord pH <7.0 and 57 (52.3%) an arterial cord pH <7.1. Almost all infants with NE were admitted to the NICU compared with only 8.2% of the infants in the control group. In addition, 89.0% of the infants with NE were intubated and 56.9% developed seizures within 24 hours of birth. Twenty-six infants with NE (23.9%) died by 28 days of life. There were no deaths in the control group.
It has been proposed that an evaluation of the EFM upon admission may be useful in determining the effect of intrapartum events on the occurrence of NE.
17 Based on this theory, if the FHR tracing was abnormal at the time of admission, then it is probable that the key aetiological factors resulting in NE preceded the onset of labour. In our study, more women in the NE group had a category II or category III FHR tracing on admission compared with women in the control group (Table 2) . This difference in EFM patterns at the time of admission likely accounts for the higher rate of delivery within 2 hours of admission among women whose infants had NE compared with the control group (29.4 vs. 7.3%, p < 0.01). Notably, 42.2% of women in the NE group had a category I FHR tracing at the time of admission. Of these women with a reassuring tracing at admission, 78% had a category II and 15% had a category III tracing prior to delivery.
Category III FHR tracings were observed in the last 30 minutes of EFM in 19 women (17.4%) whose infants had NE compared with only two women (0.9%) in the Data presented as n (%) except as noted for gestational age and minutes without monitoring, which are presented as median (interquartile range). *P < 0.01. **P < 0.05. ***Hypertensive disorders included chronic hypertension, preeclampsia, and gestational hypertension. ****Sentinel event defined as placental abruption, cord prolapse or uterine rupture. control group. Infants in the control group were more likely to have a category I tracing prior to delivery than were those in the case group, 14 (6.0%) compared with three (2.8%), respectively. In regard to the individual FHR characteristics that were assessed, women in the NE group were more likely to have bradycardia, minimal/absent variability, late decelerations and prolonged decelerations prior to delivery compared with women in the control group (Table 3) . Accelerations and the presence of any variable deceleration were more common in the control group. Similar associations between FHR characteristics and NE were seen when the NE group was restricted to those women with an umbilical artery cord pH <7.1 (Supporting Information Table S2 ), with the exception that tachycardia was also associated with NE. In addition, the association between NE and prolonged decelerations no longer reached statistical significance. Bradycardia, minimal/absent variability and late and prolonged decelerations were associated with an increased risk of NE in the subgroup of women with a category II FHR tracing prior to delivery (Supporting Information Table S3 ). When the primary analysis was repeated among only women who laboured, the results were similar, with the exception that severe variable decelerations were also associated with NE (Supporting Information Table S4 ). A wide degree of variability was observed with regard to the interobserver agreement depending of the FHR characteristic assessed. The interpretation of fetal heart rate category (j = 0.66) and tachycardia (j = 0.77) had the highest degree of agreement among observers, whereas the degree of agreement regarding the presence of accelerations, variable decelerations and prolonged decelerations was low (Table 4) .
Discussion

Main findings
Women whose infants had NE were more likely to present with a category II or III FHR tracing at the time of admission than were women in the control group, although over 40% in the NE group had a category I tracing at admission. Prior to delivery, category III FHR tracings were common among the infants with NE, yet most FHR tracings were category II during this time period regardless of whether the infant was diagnosed with NE. We found that among women with category II FHR tracings there were specific characteristics that remained associated with a higher risk of NE after adjustment for confounding.
Strengths and limitations
The use of a case-control study design is a potential limitation of this study. We demonstrated a strong association between certain EFM characteristics and NE, yet because we did not have information about the denominator, the data cannot be used to evaluate the predictive value of these EFM patterns. In addition, the use of ICD-10 coding to identify cases of NE introduces the possibility of misclassification bias. This risk was reduced by extensively reviewing the charts of participants in the study, but there remains a chance that some cases of NE were not identified. Another potential source of bias is that reviewers may have interpreted the FHR tracings more negatively because they were aware that a disproportionate number of women in the study had infants with NE compared with the general population. However, this would likely have impacted the FHR interpretation in both the NE and control groups, as the reviewers were blinded to the outcome. The generalisability of our findings to other centres and countries may also be limited. Our evaluation of the EFM prior to delivery was restricted to the last 30 minutes of available tracing. This means that we evaluated 30 minutes of FHR tracing for all women, but the duration of time between the end of the assessment and delivery varied, as some women had a period of time prior to delivery without fetal monitoring. Fortunately, the duration of time without monitoring prior to delivery was fairly short, albeit longer among women in the NE group than in the control group. This likely reflects the higher proportion of operative deliveries within this group. The last 30 minutes of tracing prior to delivery may also not reflect the characteristics of the FHR tracing more remote from delivery, which is why we chose to assess EFM at the time of admission as well. The 30-minute time period was selected because ACOG recommends that EFM is evaluated at least every 30 minutes during labour. 19 The inclusion of women who underwent emergency caesarean delivery without labour in our study may be viewed as controversial. However, the goal of our study was to evaluate the use of EFM as a tool to identify patterns associated with NE prior to delivery. Ideally, we hope that with further research, EFM can be used in the future to guide management decisions and reduce rates of NE regardless of labour status. We appreciate that the causative mechanism of NE in labouring and non-labouring women may differ, but our findings were similar when the analysis was restricted to women who laboured.
Our definition of NE was not based on umbilical cord gas results but rather on a postnatal clinical diagnosis, which may also be viewed as weakness of the study. Some cases of NE in our study would not have met the criteria for older definitions of hypoxic ischaemic encephalopathy. The definition that we used, however, is consistent with current ACOG and AAP Task Force recommendations. 1 In addition, we demonstrated consistency in our results when we performed a sensitivity analysis based on umbilical artery cord pH. Most previous EFM studies have used acidosis alone as the primary outcome, yet NE is uncommon among infants with umbilical cord acidaemia. In a recent study, less than 3% of infants with an umbilical artery cord pH ≤7.0 developed encephalopathy with seizures and/or death. 24 The few studies that have evaluated the association between EFM characteristics and NE have, unlike our study, been very small 16, 18 or lacked a control group of unaffected fetuses. 17 The participation of board-certified physicians in the blinded review of every tracing is also a major strength of our study.
Interpretation
The effectiveness of EFM as a clinical tool to improve neonatal outcomes presumes the ability to prevent permanent fetal injury before it occurs. The role of intrapartum events in the occurrence of NE is controversial. In a study published in 1998, Badawi and colleagues 25 reported that intrapartum hypoxia alone accounted for only 5% of cases of NE. In contrast, in a more recent study, investigators found that although certain antenatal factors may predispose an infant to hypoxaemic ischaemic encephalopathy, intrapartum factors were identified in 90% of cases. 26 An evaluation of EFM at the time of admission may provide some indication of causal timing of an event. In our study, only four women whose infants had NE presented with a category III FHR tracing at the time of admission, but the prevalence of a category II tracing at the time of admission was higher in the NE group than in the control group. If a category II FHR tracing is assumed to be potentially pathologic, then this could suggest that in many cases of NE, pathological processes had either already occurred or were evolving at the time of admission. However, it should be noted that 42.2% of women in the NE group presented with a category I tracing. It is within this group that we would hypothesise that obstetrical interventions might have the greatest chance of modifying the risk of NE.
Some events during labour, such as cord prolapse, placental abruption or uterine rupture, clearly predispose an infant to NE. However, the role of EFM in influencing the risk associated with these sentinel events may be limited. Sentinel events were more common in the NE group than the control group in our study but preceded delivery in only 13.8% of cases.
The rate of category III FHR tracings prior to delivery among the cases of NE in our study (17.4%) is higher than has been reported in previous studies. In a large retrospective cohort study that enrolled consecutive term births at a single centre, Cahill and colleagues 14 reported an incidence of category III FHR tracings within the 30 minutes prior to delivery of <0.01%. No category III FHR tracings were seen among the 57 cases of neonatal acidaemia in their study. Conversely, in a case-control study, Graham et al. 18 found that the presence of a category III FHR tracing prior to delivery among cases of NE was 12.8%. These data suggest that category III tracings, although very infrequent in an unselected population, are not uncommon among fetuses who develop NE.
In contrast, category II FHR tracings are frequently encountered during labour and are the most difficult to manage. Category II FHR tracings include all the EFM patterns that do not meet the more stringent criteria of categories I and III, and therefore the clinical significance of individual patterns within this group can vary widely. 27 Strategies to discriminate among category II FHR tracings based on the risk of adverse neonatal outcomes are needed. 28 Minimal/absent variability and late and prolonged decelerations were independently associated with NE among women with a category II FHR tracing in our study. Perhaps not surprisingly, these are the same factors that have been found to be associated with low umbilical artery cord pH in previous studies.
11 -14,16 While this finding suggests that an emphasis on the identification of these specific characteristics may be useful, this conclusion is tempered by the finding of low interobserver agreement in the identification of late and prolonged decelerations. The much higher level of agreement among reviewers as regards category, would support the continued use of the three-tiered system as the primary framework for EFM interpretation.
Conclusion
Obstetric interventions will not prevent all cases of NE; however, our data suggest that there is an association between certain EFM patterns and this clinically important neonatal outcome. Utilisation of EFM as a tool to reduce rates of NE requires an advanced understanding of how EFM patterns relate to NE. This work validates the recommended interpretation of category III FHR tracings as pathologic, and our results suggest that an increased focus on variability and the presence of late and prolonged decelerations may improve the management of category II tracings. We support the continued use of the three-tiered system because of its high reliability but recommend that future research should address further discrimination among category II tracings and investigate how obstetric management in response to EFM patterns may mitigate adverse neonatal outcomes.
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